In Vitro Cytotoxicity Testing
We currently have over 500 mammalian cell lines, 370 different human cancer cell lines, as well as numerous primary human cells (e.g., HEKa, HUVEC, HMVEC, NHDF, NHEK, PBMC). We can analyze the biological activity of your compound by itself or in combination with other known chemotherapeutic agents, see list below.
Please contact us with any request for cell-based toxicity testing. We can perform any non -radioactive cytotoxicity assay (e.g. The MultiTox-Glo Multiplex Cytotoxicity Assay, ApoGlow). Moreover, we can order any new cell line and custom develop your assay as requested.
These are the 29 anti-cancer drugs currently available for research purposes at SBH Sciences:
| Adrucil - Fluorouracil (5FU) Artesunate Artemisinin Avastin Bortezomib (Valcade) Camptothecin Carboplatin Cyclophosphamide (Cytoxan) Cisplatin (data), cisplatinum or cis- Diamminedichloroplatinum (II) (data) Dasatinib |
Doxorubicin (data) Erlotinib (data) Etoposide Gefitinib (Iressa) Gemcitabine Hydrochloride Imatinib (Gleevec) Irinotecan HCl Ifosfamide Leptomycin B Mitomycin C (data) Neomycin Sulfate |
a-Solanine Paclitaxel (Taxol) Sorafenib Staurosporine Tamoxifen Tomatine Vinblastine Vincristine |
SBH Sciences collaborated with Karyopharm Therapeutics in its anti-cancer development program, evaluating over 200 cancer cell lines, to screen for a potential anti-cancer drug. SBH Sciences and Karyopharm Therapeutics have also presented ten scientific abstracts together.